One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2018-99-115163
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 37 |
Affiliation: Janssen (United States), Icahn School of Medicine at Mount Sinai, University of Mannheim, Heidelberg University, University Hospital Heidelberg, University of Bologna, University of Chicago, Délégation Paris 7, Hôpital Saint-Louis, Université Paris Cité, Azienda ospedaliera "Bianchi-Melacrino-Morelli", University Hospital Leipzig, Moffitt Cancer Center, University of Maryland, Baltimore, Fred Hutch Cancer CenterImetelstat Is Effective Treatment for Patients with Intermediate-2 or High-Risk Myelofibrosis Who Have Relapsed on or Are Refractory to Janus Kinase Inhibitor Therapy: Results of a Phase 2 Randomized Study of Two Dose Levels
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
